JUNS (Jupiter Neurosciences) Earnings per share growth rate in current year
The prospects for Jupiter Neurosciences Inc (JUNS) are driven by the success of JUP-001 in combating Alzheimer's and its orphan drug status. The YoY EPS volatility confirms the strength of this trend, where 0.00 represents the current level of the metric. A unique oral delivery system ensures margin resilience. The strategy is completed by the implementation of ESG principles in the laboratories, ensuring the bioethics of all clinical trials and data transparency.
Financial and market metric breakdowns for jupiterneurosciences.com (JUNS)
- share price and expert price forecast:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Debt to Equity Ratio Jupiter Neurosciences Inc|JUNS - Long-Term Debt to Capital|Current Liabilities to Capital Jupiter Neurosciences Inc|JUNS - Company Total Debt|Debts to Book Capitalization Jupiter Neurosciences Inc|JUNS - Company Long-Term Debt|Company Short-Term Loans and Borrowings Jupiter Neurosciences|Immediate Liquidity jupiterneurosciences.com
- net income and valuation multiples indicators:
JUNS - Company Net Income|Company Profit Forecast Jupiter Neurosciences Inc|JUNS - P/E Multiple|Projected Price to Earnings Jupiter Neurosciences Inc|JUNS - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jupiter Neurosciences|JUNS - Operating profit EBITDA|Net earnings per one share for the last twelve months Jupiter Neurosciences|JUNS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months jupiterneurosciences.com|JUNS - Earnings growth in current year|Expected earnings per share growth for next year Jupiter Neurosciences Inc
- company sales and revenue statistics:
Summary company analysis:Jupiter Neurosciences Inc
Business resilience analysis requires assessing a company's ability to maintain profitability amidst volatility. For Jupiter Neurosciences Inc (JUNS), success depends on drug bioavailability and patent protection. The annual earnings per share growth profile measures the percentage change in EPS over a year, filtering out market noise. This indicator reflects the real efficiency of each share of capital. The trend of this metric confirms the fundamental reliability of the investments.
Main competitors
Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE
